Skip to Main Content

Author Details

Brian Wolf
Nassau University Medical Center
2015
9
5
PMIDPaper TitleJournal TitlePublished Year
33187940"Ossifying" mucoepidermoid carcinoma: A deceptive clinical presentation.Oral Surg Oral Med Oral Pathol Oral Radiol2021
33187940"Ossifying" mucoepidermoid carcinoma: A deceptive clinical presentation.Oral Surg Oral Med Oral Pathol Oral Radiol2021
28712979Clinical Implications of the T790M Mutation in Disease Characteristics and Treatment Response in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC).Clin Lung Cancer2018
28712979Clinical Implications of the T790M Mutation in Disease Characteristics and Treatment Response in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC).Clin Lung Cancer2018
29874546A Phase II Study of Pembrolizumab in EGFR-Mutant, PD-L1+, Tyrosine Kinase Inhibitor Naïve Patients With Advanced NSCLC.J Thorac Oncol2018
29382669Treatment-Related Adverse Events Predict Improved Clinical Outcome in NSCLC Patients on KEYNOTE-001 at a Single Center.Cancer Immunol Res2018
29555183Toxic Epidermal Necrolysis: A Dermatologic Emergency and the Role of the Oral and Maxillofacial Surgeon.J Oral Maxillofac Surg2018
29232184Feasibility and Safety of Intrathoracic Biopsy and Repeat Biopsy for Evaluation of Programmed Cell Death Ligand-1 Expression for Immunotherapy in Non-Small Cell Lung Cancer.Radiology2018
29874546A Phase II Study of Pembrolizumab in EGFR-Mutant, PD-L1+, Tyrosine Kinase Inhibitor Naïve Patients With Advanced NSCLC.J Thorac Oncol2018
29555183Toxic Epidermal Necrolysis: A Dermatologic Emergency and the Role of the Oral and Maxillofacial Surgeon.J Oral Maxillofac Surg2018
29382669Treatment-Related Adverse Events Predict Improved Clinical Outcome in NSCLC Patients on KEYNOTE-001 at a Single Center.Cancer Immunol Res2018
29232184Feasibility and Safety of Intrathoracic Biopsy and Repeat Biopsy for Evaluation of Programmed Cell Death Ligand-1 Expression for Immunotherapy in Non-Small Cell Lung Cancer.Radiology2018
29125624Non-small cell lung cancer clinical trials requiring biopsies with biomarker-specific results for enrollment provide unique challenges.Cancer2017
29125624Non-small cell lung cancer clinical trials requiring biopsies with biomarker-specific results for enrollment provide unique challenges.Cancer2017
25618216Representing and extracting lung cancer study metadata: study objective and study design.Comput Biol Med2015
27279233Clinical Trials in Non-Small Cell Lung Cancer with Biomarker-Driven Treatment Allocation: Ready or Not, Here We Come.Crit Rev Oncog2015
27279233Clinical Trials in Non-Small Cell Lung Cancer with Biomarker-Driven Treatment Allocation: Ready or Not, Here We Come.Crit Rev Oncog2015
25618216Representing and extracting lung cancer study metadata: study objective and study design.Comput Biol Med2015
  • 1 - 18 of 18

Recommended Authors

University of California San Diego
Career Start Year 2017
Number of shared co-authors 0
David Geffen School of Medicine University of California Los Angeles California USA.
Career Start Year 2016
Number of shared co-authors 2
University of Arkansas for Medical Sciences
Career Start Year 2015
Number of shared co-authors 0
Macquarie University
Career Start Year 2012
Number of shared co-authors 0
Moores Cancer Center, University of California San Diego
Career Start Year 2010
Number of shared co-authors 0
Western University
Career Start Year 2009
Number of shared co-authors 0
University of Washington
Career Start Year 2009
Number of shared co-authors 0
University of California San Diego Health
Career Start Year 2008
Number of shared co-authors 0
Royal Prince Alfred Hospital
Career Start Year 2007
Number of shared co-authors 0
12235University of Miami Miller School of Medicine
Career Start Year 2007
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2006
Number of shared co-authors 0
University of Tokyo
Career Start Year 2005
Number of shared co-authors 0
University of California San Diego Moores Cancer Center La Jolla California USA.
Career Start Year 2005
Number of shared co-authors 0
Westmead Hospital
Career Start Year 2004
Number of shared co-authors 0
Tufts Medical Center
Career Start Year 2004
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 2
The University of Texas M. D. Anderson Cancer Center
Career Start Year 2001
Number of shared co-authors 0
Schulich School of Medicine and Dentistry, Western University
Career Start Year 2000
Number of shared co-authors 0
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Career Start Year 1999
Number of shared co-authors 0
Universidade Federal do Rio Grande do Sul
Career Start Year 1999
Number of shared co-authors 0
Schulich School of Medicine & Dentistry, Western University
Career Start Year 1998
Number of shared co-authors 0
Stanford University
Career Start Year 1996
Number of shared co-authors 0
Woodland Hills Medical Center
Career Start Year 1996
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 0
Prince of Wales Hospital
Career Start Year 1995
Number of shared co-authors 0
Oxford University Hospitals NHS Foundation Trust
Career Start Year 1995
Number of shared co-authors 0
University of Chicago Pritzker School of Medicine
Career Start Year 1993
Number of shared co-authors 1
Jonsson Comprehensive Cancer Center, University of California los angeles
Career Start Year 1992
Number of shared co-authors 7
Samuel Oschin Comprehensive Cancer Center
Career Start Year 1974
Number of shared co-authors 0
Peter MacCallum Cancer Centre
Career Start Year 1973
Number of shared co-authors 1

Collaborators

David Geffen School of Medicine, University of California Los Angeles
Co-authored papers 7
David Geffen School of Medicine at university of california los angeles
Co-authored papers 5
David Geffen School of Medicine at university of california los angeles
Co-authored papers 5
David Geffen School of Medicine, University of California Los Angeles
Co-authored papers 4
David Geffen School of Medicine at university of california los angeles
Co-authored papers 4
David Geffen School of Medicine at the University of California los angeles
Co-authored papers 4
Jonsson Comprehensive Cancer Center, university of california los angeles
Co-authored papers 3
University of California los angeles
Co-authored papers 2
University of California los angeles
Co-authored papers 2
David Geffen School of Medicine, University of California los angeles
Co-authored papers 2
Oregon Health & Science University
Co-authored papers 2
David Geffen School of Medicine at University of California los angeles
Co-authored papers 2
University of California los angeles
Co-authored papers 1
David Geffen School of Medicine at the University of California los angeles
Co-authored papers 1
David Geffen School of Medicine at university of california los angeles
Co-authored papers 1
University of California los angeles
Co-authored papers 1
Co-authored papers 1
University of California Los Angeles
Co-authored papers 1
David Geffen School of Medicine at University of California Los Angeles
Co-authored papers 1
University of California los angeles
Co-authored papers 1
University of California los angeles
Co-authored papers 1
Loma Linda University
Co-authored papers 1
David Geffen School of Medicine, University of California los angeles
Co-authored papers 1
university of california los angeles School of Medicine
Co-authored papers 1
University of California Los Angeles
Co-authored papers 1
University of California los angeles
Co-authored papers 1